TRINOMAB BIOTECH CO., LTD.
泰诺麦博
TRINOMAB BIOTECH CO., LTD.
Biotech/Healthcare
Zhuhai Trinomab Biotechnology Co., Ltd. is an innovative biotechnology company focused on developing immunotherapies and fully human antibody drugs for major diseases, including cancer, autoimmune disorders, and infectious diseases, as well as providing related technical services.
Latest round: IPO (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.